ALEXNG88
2021-09-14
[微笑]
Busy IPO market this week poised to make 2021 the biggest year ever by proceeds<blockquote>本周繁忙的IPO市场有望使2021年成为有史以来收益最大的一年</blockquote>
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
7
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":886541841,"tweetId":"886541841","gmtCreate":1631609144283,"gmtModify":1631890088309,"author":{"id":3569303927346238,"idStr":"3569303927346238","authorId":3569303927346238,"authorIdStr":"3569303927346238","name":"ALEXNG88","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":6,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p><span>[微笑] </span></p></body></html>","htmlText":"<html><head></head><body><p><span>[微笑] </span></p></body></html>","text":"[微笑]","highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/886541841","repostId":1160275332,"repostType":4,"repost":{"id":"1160275332","kind":"news","pubTimestamp":1631604098,"share":"https://www.laohu8.com/m/news/1160275332?lang=zh_CN&edition=full","pubTime":"2021-09-14 15:21","market":"us","language":"en","title":"Busy IPO market this week poised to make 2021 the biggest year ever by proceeds<blockquote>本周繁忙的IPO市场有望使2021年成为有史以来收益最大的一年</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1160275332","media":"MarketWatch","summary":"Swiss running-shoe company backed by Roger Federer and drive-through coffee chain expected to hit th","content":"<p>Swiss running-shoe company backed by Roger Federer and drive-through coffee chain expected to hit the market this week </p><p><blockquote>罗杰·费德勒支持的瑞士跑鞋公司和得来速咖啡连锁店预计将于本周上市</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/18111af5f5bda21b3128860fe616c5ca\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Swiss tennis giant Roger Federer is a backer of one of this week's bigger IPOs.</span></p><p><blockquote><p class=\"t-img-caption\"><span>瑞士网球巨头罗杰·费德勒是本周最大IPO之一的支持者。</span></p></blockquote></p><p> After a flurry of initial-public-offering launches last week set the market up for a busy fall for deals, 11 are expected to price this week and raise more than $3 billion in proceeds. </p><p><blockquote>上周一系列首次公开募股引发市场交易繁忙，预计本周将有11家公司定价，筹集超过30亿美元的资金。</blockquote></p><p> If all deals materialize, it will make 2021 the biggest year for IPO proceeds ever, and shatter the previous record by about 30%, according to Bill Smith, founder and chief executive of Renaissance Capital, a provider of institutional research and exchange-traded funds oriented around IPOs. The market is expected to see some 375 deals for the year, raising $125 billion, according to Renaissance, beating the $97 billion raised in 2000 during the dot-com boom. </p><p><blockquote>机构研究和交易所交易基金提供商Renaissance Capital创始人兼首席执行官比尔·史密斯(Bill Smith)表示，如果所有交易都实现，2021年将成为有史以来IPO收益最大的一年，并将之前的记录打破约30%。以IPO为导向的基金。据Renaissance称，预计今年市场将出现约375笔交易，筹集1250亿美元，超过2000年互联网繁荣期间筹集的970亿美元。</blockquote></p><p> “After the long summer break, this week is a litmus test for upcoming tech, biotech, and consumer IPOs,” Smith wrote in a market commentary. The list includes a Swiss running-shoe company backed by tennis giant Roger Federer, a drive-through coffee kiosk operator and a mortgage insurer that was spun out of insurer Genworth Financial. </p><p><blockquote>史密斯在市场评论中写道：“在漫长的暑假之后，本周是即将到来的科技、生物技术和消费者IPO的试金石。”该名单包括一家由网球巨头罗杰·费德勒支持的瑞士跑鞋公司、一家得来速咖啡亭运营商以及一家从保险公司Genworth Financial分拆出来的抵押贷款保险公司。</blockquote></p><p> The biggest deal of the week is expected to come from Thoughtworks,a Chicago-based technology consultancy that will go public at a valuation of up to $6.1 billion.</p><p><blockquote>本周最大的交易预计将来自总部位于芝加哥的技术咨询公司Thoughtworks，该公司将以高达61亿美元的估值上市。</blockquote></p><p> The company, which expects to change its name from Turing Holding Corp. to Thoughtworks with completion of the IPO, said a total of 36.84 million shares will be offered, split between the company and selling shareholders.</p><p><blockquote>该公司预计在IPO完成后将更名从Turing Holding Corp.更名为Thoughtworks，并表示将发行总计3684万股股票，由公司和出售股东分配。</blockquote></p><p> The deal is expected to price at between $18 and $20 a share, and the stock will trade on the Nasdaq under the ticker symbol “TWKS.” Goldman Sachs and JPMorgan are the lead underwriters. The company recorded net income of $79.3 million on revenue of $803.4 million in 2020, after income of $28.4 million on revenue of $772.2 million in 2019.</p><p><blockquote>这笔交易预计价格为每股18美元至20美元，股票将在纳斯达克交易，股票代码为“TWKS”。高盛和摩根大通是主承销商。本公司于2020年录得净收入79.3百万美元，收入为8.03.4百万美元，二零一九年录得7.72.2百万美元后，收入净额为2840万美元。</blockquote></p><p> The Swiss athletic-footwear maker On Holding is expected to raise up to $622 million at a valuation of almost $6 billion. On has applied to list 31.1 million shares priced at $18 to $20 each on the New York Stock Exchange, under the ticker symbol “ONON.”</p><p><blockquote>这家持有股份的瑞士运动鞋制造商预计将以近60亿美元的估值筹集至多6.22亿美元。On已申请在纽约证券交易所上市3110万股，每股价格为18至20美元，股票代码为“ONON”。</blockquote></p><p> Goldman Sachs, Morgan Stanley and Morgan Stanley are lead underwriters in a syndicate of nine banks on the On deal. Proceeds are to be used for general corporate purposes. The company has a line that it co-developed with Federer.</p><p><blockquote>高盛、摩根士丹利和摩根士丹利是此次交易的九家银行组成的银团的主承销商。收益将用于一般公司用途。该公司有一条与费德勒共同开发的生产线。</blockquote></p><p> The company had net income of 3.8 million Swiss francs ($4.1 million) in the six months through June 30, after a loss of 33.1 million francs in the year-earlier period, according to its IPO documents. Sales came to 315.5 million francs, up from 170.9 million francs.</p><p><blockquote>根据其IPO文件，在截至6月30日的六个月中，该公司的净利润为380万瑞士法郎（合410万美元），而上年同期为亏损3310万瑞士法郎，而去年同期的销售额为3.155亿瑞士法郎，高于1.709亿瑞士法郎。</blockquote></p><p> Also from Switzerland, sports betting site Sportrader Group AG plans to offer 19 million shares priced at $25 to $28 each, for a valuation of up to $31 billion. The company has applied to list on Nasdaq under the ticker symbol “SRAD.” JPMorgan, Morgan Stanley, Citigroup and UBS are lead underwriters in a syndicate of 13 banks working on the deal.</p><p><blockquote>同样来自瑞士的体育博彩网站Sportrader Group AG计划以每股25至28美元的价格发行1900万股股票，估值高达310亿美元。该公司已申请在纳斯达克上市，股票代码为“SRAD”。摩根大通、摩根士丹利、花旗集团和瑞银是参与该交易的13家银行组成的银团的主承销商。</blockquote></p><p> Proceeds are to be used for working capital and to spur growth. The company had a net profit of $29.9 million in the first six months of the year, on revenue of $321 million, according to its filing documents.</p><p><blockquote>收益将用于营运资金和刺激增长。根据其备案文件，该公司今年前六个月净利润为2990万美元，营收为3.21亿美元。</blockquote></p><p> Dutch Bros Inc.,an operator of drive-through shops that serve hot and cold drinks mostly in western U.S. states, is planning to offer 21.1 million shares priced at $18 to $20 each in its IPO, valuing the company at up to $3.3 billion.</p><p><blockquote>Dutch Bros Inc.是一家主要在美国西部各州提供冷热饮料的免下车商店运营商，计划在IPO中发行2110万股股票，每股价格为18至20美元，公司估值高达33亿美元。</blockquote></p><p> BofA Securities, JPMorgan and Jefferies are lead underwriters in a syndicate of 13 banks working on the deal. The company has applied to list on the New York Stock Exchange under the ticker symbol “BROS.”</p><p><blockquote>美国银行证券、摩根大通和杰富瑞是参与该交易的13家银行组成的财团的主承销商。该公司已申请在纽约证券交易所上市，股票代码为“BROS”。</blockquote></p><p> Proceeds are to be used to purchase additional Class A shares — the company is planning to have four classes of stock with differing voting rights. The company had a net loss of $13.6 million, or 32 cents a share, in the first six months of the year, narrower than the loss of $16.5 million, or 38 cents a share, posted in the year-earlier period. Revenue fell to $227.9 million from $327.4 million.</p><p><blockquote>所得款项将用于购买额外的A类股票——该公司计划拥有四类具有不同投票权的股票。该公司今年前六个月的净亏损为1,360万美元，即每股亏损32美分，低于去年同期的1,650万美元，即每股亏损38美分。收入从3.274亿美元降至2.279亿美元。</blockquote></p><p> <b>Rounding out the list are:</b></p><p><blockquote><b>名单上还有：</b></blockquote></p><p> • Definitive Healthcare Corp., a Massachusetts-based provider of healthcare commercial intelligence, is planning to offer 15.56 million shares in its PO, which is expected to price between $21 and $24 a share. At that pricing, the company could be valued at up to $3.55 billion.</p><p><blockquote>•总部位于马萨诸塞州的医疗保健商业情报提供商Definitive Healthcare Corp.计划在其PO中发行1556万股股票，预计定价在每股21美元至24美元之间。按照这个定价，该公司的估值可能高达35.5亿美元。</blockquote></p><p></p><p> • Enact Holdings Inc., a mortgage insurer owned by Genworth, is planning to offer 13.3 million shares priced at $19 to $20 each. The company would be valued at $3.3 billion at the top of that range. The company said all shares will be sold by Genworth and it will not receive any proceeds. It has applied to list on Nasdaq under the ticker “ACT.” Goldman Sachs and JPMorgan are lead underwriters in a team of nine banks working on the deal.</p><p><blockquote>Genworth旗下的抵押贷款保险公司Enact Holdings Inc.计划发行1330万股股票，每股价格为19至20美元。该公司的估值为33亿美元，处于该范围的顶部。该公司表示，Genworth将出售所有股份，不会获得任何收益。它已申请在纳斯达克上市，股票代码为“ACT”。高盛和摩根大通是参与该交易的九家银行团队的主承销商。</blockquote></p><p> • ForgeRock<a href=\"https://www.marketwatch.com/investing/stock/FORG?mod=MW_story_quote&mod=article_inline\" target=\"_blank\">,</a> a California-based identity security platform, is looking to raise up to $264 million with an offering of 11 million shares priced between $21 and $24 a share. That pricing would value the company a valuation of up to $1.91 billion.</p><p><blockquote>•锻造岩石<a href=\"https://www.marketwatch.com/investing/stock/FORG?mod=MW_story_quote&mod=article_inline\" target=\"_blank\">,</a>一家总部位于加州的身份安全平台希望通过发行1100万股股票，每股价格在21美元至24美元之间，筹集至多2.64亿美元。该定价将使该公司估值高达19.1亿美元。</blockquote></p><p> The stock is expected to list on the NYSE under the ticker symbol “FORG.” Morgan Stanley and JPMorgan are the lead underwriters. The company recorded a net loss of $41.8 million on revenue of $127.6 million in 2020, after a loss of $36.9 million on revenue of $104.5 million in 2019.</p><p><blockquote>该股预计将在纽约证券交易所上市，股票代码为“FORG”。摩根士丹利和摩根大通是主承销商。该公司在2020年录得净亏损4180万美元，营收为1.276亿美元，而2019年营收为1.045亿美元，亏损3690万美元。</blockquote></p><p> <b>•</b>Dice Therapeutics is expected to raise up to $170 million at a valuation of up to $583 million and list on Nasdaq under the ticker symbol “DICE.” The biotech is developing therapies to treat chronic diseases in the field of immunology.</p><p><blockquote><b>•</b>Dice Therapeutics预计将以高达5.83亿美元的估值筹集至多1.7亿美元，并在纳斯达克上市，股票代码为“DICE”。该生物技术公司正在免疫学领域开发治疗慢性疾病的疗法。</blockquote></p><p> <b>•</b>Surgical robotics developer Procept BioRobotics,is aiming to raise up to $132 million at a valuation of about $1 billion with plans to list on Nasdaq under the ticker symbol “PRCT.” BofA Securities and Goldman Sachs are lead underwriters.</p><p><blockquote><b>•</b>手术机器人开发商Procept BioRobotics计划以约10亿美元的估值筹集至多1.32亿美元，并计划在纳斯达克上市，股票代码为“PRCT”。美银证券和高盛是主承销商。</blockquote></p><p> “We develop, manufacture and sell the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia, or BPH,” the company says in its IPO documents.</p><p><blockquote>该公司在其IPO文件中表示：“我们开发、制造和销售AquaBeam机器人系统，这是一种先进的图像引导手术机器人系统，用于微创泌尿外科手术，最初重点是治疗良性前列腺增生（BPH）。”</blockquote></p><p> <b>•</b>Tyra Biosciences is aiming to raise $107.2 million in IPO proceeds at a valuation of $589 million. The biotech’s leading product candidate is a treatment for bladder cancer. It has applied to list on Nasdaq under the symbol “TYRA.”</p><p><blockquote><b>•</b>Tyra Biosciences的目标是通过IPO筹集1.072亿美元，估值为5.89亿美元。该生物技术公司的领先候选产品是膀胱癌的治疗方法。它已申请在纳斯达克上市，股票代码为“TYRA”。</blockquote></p><p> <b>•</b>EzFill Holdings, an app-based mobile fueling company in South Florida, is planning to raise $25 million at a valuation of $100 million. The company has applied to list on Nasdaq under the ticker symbol “EZFL.” ThinkEquity is sole underwriter.</p><p><blockquote><b>•</b>EzFill Holdings是一家位于南佛罗里达州的基于应用程序的移动加油公司，计划以1亿美元的估值筹集2500万美元。该公司已申请在纳斯达克上市，股票代码为“EZFL”。ThinkEquity是独家承销商。</blockquote></p><p> The Renaissance IPO ETF has gained 6% to date in 2021, while the S&P 500 has advanced 19%.</p><p><blockquote>2021年迄今为止，Renaissance IPO ETF已上涨6%，而标普500则上涨19%。</blockquote></p><p></p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Busy IPO market this week poised to make 2021 the biggest year ever by proceeds<blockquote>本周繁忙的IPO市场有望使2021年成为有史以来收益最大的一年</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBusy IPO market this week poised to make 2021 the biggest year ever by proceeds<blockquote>本周繁忙的IPO市场有望使2021年成为有史以来收益最大的一年</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">MarketWatch</strong><span class=\"h-time small\">2021-09-14 15:21</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Swiss running-shoe company backed by Roger Federer and drive-through coffee chain expected to hit the market this week </p><p><blockquote>罗杰·费德勒支持的瑞士跑鞋公司和得来速咖啡连锁店预计将于本周上市</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/18111af5f5bda21b3128860fe616c5ca\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Swiss tennis giant Roger Federer is a backer of one of this week's bigger IPOs.</span></p><p><blockquote><p class=\"t-img-caption\"><span>瑞士网球巨头罗杰·费德勒是本周最大IPO之一的支持者。</span></p></blockquote></p><p> After a flurry of initial-public-offering launches last week set the market up for a busy fall for deals, 11 are expected to price this week and raise more than $3 billion in proceeds. </p><p><blockquote>上周一系列首次公开募股引发市场交易繁忙，预计本周将有11家公司定价，筹集超过30亿美元的资金。</blockquote></p><p> If all deals materialize, it will make 2021 the biggest year for IPO proceeds ever, and shatter the previous record by about 30%, according to Bill Smith, founder and chief executive of Renaissance Capital, a provider of institutional research and exchange-traded funds oriented around IPOs. The market is expected to see some 375 deals for the year, raising $125 billion, according to Renaissance, beating the $97 billion raised in 2000 during the dot-com boom. </p><p><blockquote>机构研究和交易所交易基金提供商Renaissance Capital创始人兼首席执行官比尔·史密斯(Bill Smith)表示，如果所有交易都实现，2021年将成为有史以来IPO收益最大的一年，并将之前的记录打破约30%。以IPO为导向的基金。据Renaissance称，预计今年市场将出现约375笔交易，筹集1250亿美元，超过2000年互联网繁荣期间筹集的970亿美元。</blockquote></p><p> “After the long summer break, this week is a litmus test for upcoming tech, biotech, and consumer IPOs,” Smith wrote in a market commentary. The list includes a Swiss running-shoe company backed by tennis giant Roger Federer, a drive-through coffee kiosk operator and a mortgage insurer that was spun out of insurer Genworth Financial. </p><p><blockquote>史密斯在市场评论中写道：“在漫长的暑假之后，本周是即将到来的科技、生物技术和消费者IPO的试金石。”该名单包括一家由网球巨头罗杰·费德勒支持的瑞士跑鞋公司、一家得来速咖啡亭运营商以及一家从保险公司Genworth Financial分拆出来的抵押贷款保险公司。</blockquote></p><p> The biggest deal of the week is expected to come from Thoughtworks,a Chicago-based technology consultancy that will go public at a valuation of up to $6.1 billion.</p><p><blockquote>本周最大的交易预计将来自总部位于芝加哥的技术咨询公司Thoughtworks，该公司将以高达61亿美元的估值上市。</blockquote></p><p> The company, which expects to change its name from Turing Holding Corp. to Thoughtworks with completion of the IPO, said a total of 36.84 million shares will be offered, split between the company and selling shareholders.</p><p><blockquote>该公司预计在IPO完成后将更名从Turing Holding Corp.更名为Thoughtworks，并表示将发行总计3684万股股票，由公司和出售股东分配。</blockquote></p><p> The deal is expected to price at between $18 and $20 a share, and the stock will trade on the Nasdaq under the ticker symbol “TWKS.” Goldman Sachs and JPMorgan are the lead underwriters. The company recorded net income of $79.3 million on revenue of $803.4 million in 2020, after income of $28.4 million on revenue of $772.2 million in 2019.</p><p><blockquote>这笔交易预计价格为每股18美元至20美元，股票将在纳斯达克交易，股票代码为“TWKS”。高盛和摩根大通是主承销商。本公司于2020年录得净收入79.3百万美元，收入为8.03.4百万美元，二零一九年录得7.72.2百万美元后，收入净额为2840万美元。</blockquote></p><p> The Swiss athletic-footwear maker On Holding is expected to raise up to $622 million at a valuation of almost $6 billion. On has applied to list 31.1 million shares priced at $18 to $20 each on the New York Stock Exchange, under the ticker symbol “ONON.”</p><p><blockquote>这家持有股份的瑞士运动鞋制造商预计将以近60亿美元的估值筹集至多6.22亿美元。On已申请在纽约证券交易所上市3110万股，每股价格为18至20美元，股票代码为“ONON”。</blockquote></p><p> Goldman Sachs, Morgan Stanley and Morgan Stanley are lead underwriters in a syndicate of nine banks on the On deal. Proceeds are to be used for general corporate purposes. The company has a line that it co-developed with Federer.</p><p><blockquote>高盛、摩根士丹利和摩根士丹利是此次交易的九家银行组成的银团的主承销商。收益将用于一般公司用途。该公司有一条与费德勒共同开发的生产线。</blockquote></p><p> The company had net income of 3.8 million Swiss francs ($4.1 million) in the six months through June 30, after a loss of 33.1 million francs in the year-earlier period, according to its IPO documents. Sales came to 315.5 million francs, up from 170.9 million francs.</p><p><blockquote>根据其IPO文件，在截至6月30日的六个月中，该公司的净利润为380万瑞士法郎（合410万美元），而上年同期为亏损3310万瑞士法郎，而去年同期的销售额为3.155亿瑞士法郎，高于1.709亿瑞士法郎。</blockquote></p><p> Also from Switzerland, sports betting site Sportrader Group AG plans to offer 19 million shares priced at $25 to $28 each, for a valuation of up to $31 billion. The company has applied to list on Nasdaq under the ticker symbol “SRAD.” JPMorgan, Morgan Stanley, Citigroup and UBS are lead underwriters in a syndicate of 13 banks working on the deal.</p><p><blockquote>同样来自瑞士的体育博彩网站Sportrader Group AG计划以每股25至28美元的价格发行1900万股股票，估值高达310亿美元。该公司已申请在纳斯达克上市，股票代码为“SRAD”。摩根大通、摩根士丹利、花旗集团和瑞银是参与该交易的13家银行组成的银团的主承销商。</blockquote></p><p> Proceeds are to be used for working capital and to spur growth. The company had a net profit of $29.9 million in the first six months of the year, on revenue of $321 million, according to its filing documents.</p><p><blockquote>收益将用于营运资金和刺激增长。根据其备案文件，该公司今年前六个月净利润为2990万美元，营收为3.21亿美元。</blockquote></p><p> Dutch Bros Inc.,an operator of drive-through shops that serve hot and cold drinks mostly in western U.S. states, is planning to offer 21.1 million shares priced at $18 to $20 each in its IPO, valuing the company at up to $3.3 billion.</p><p><blockquote>Dutch Bros Inc.是一家主要在美国西部各州提供冷热饮料的免下车商店运营商，计划在IPO中发行2110万股股票，每股价格为18至20美元，公司估值高达33亿美元。</blockquote></p><p> BofA Securities, JPMorgan and Jefferies are lead underwriters in a syndicate of 13 banks working on the deal. The company has applied to list on the New York Stock Exchange under the ticker symbol “BROS.”</p><p><blockquote>美国银行证券、摩根大通和杰富瑞是参与该交易的13家银行组成的财团的主承销商。该公司已申请在纽约证券交易所上市，股票代码为“BROS”。</blockquote></p><p> Proceeds are to be used to purchase additional Class A shares — the company is planning to have four classes of stock with differing voting rights. The company had a net loss of $13.6 million, or 32 cents a share, in the first six months of the year, narrower than the loss of $16.5 million, or 38 cents a share, posted in the year-earlier period. Revenue fell to $227.9 million from $327.4 million.</p><p><blockquote>所得款项将用于购买额外的A类股票——该公司计划拥有四类具有不同投票权的股票。该公司今年前六个月的净亏损为1,360万美元，即每股亏损32美分，低于去年同期的1,650万美元，即每股亏损38美分。收入从3.274亿美元降至2.279亿美元。</blockquote></p><p> <b>Rounding out the list are:</b></p><p><blockquote><b>名单上还有：</b></blockquote></p><p> • Definitive Healthcare Corp., a Massachusetts-based provider of healthcare commercial intelligence, is planning to offer 15.56 million shares in its PO, which is expected to price between $21 and $24 a share. At that pricing, the company could be valued at up to $3.55 billion.</p><p><blockquote>•总部位于马萨诸塞州的医疗保健商业情报提供商Definitive Healthcare Corp.计划在其PO中发行1556万股股票，预计定价在每股21美元至24美元之间。按照这个定价，该公司的估值可能高达35.5亿美元。</blockquote></p><p></p><p> • Enact Holdings Inc., a mortgage insurer owned by Genworth, is planning to offer 13.3 million shares priced at $19 to $20 each. The company would be valued at $3.3 billion at the top of that range. The company said all shares will be sold by Genworth and it will not receive any proceeds. It has applied to list on Nasdaq under the ticker “ACT.” Goldman Sachs and JPMorgan are lead underwriters in a team of nine banks working on the deal.</p><p><blockquote>Genworth旗下的抵押贷款保险公司Enact Holdings Inc.计划发行1330万股股票，每股价格为19至20美元。该公司的估值为33亿美元，处于该范围的顶部。该公司表示，Genworth将出售所有股份，不会获得任何收益。它已申请在纳斯达克上市，股票代码为“ACT”。高盛和摩根大通是参与该交易的九家银行团队的主承销商。</blockquote></p><p> • ForgeRock<a href=\"https://www.marketwatch.com/investing/stock/FORG?mod=MW_story_quote&mod=article_inline\" target=\"_blank\">,</a> a California-based identity security platform, is looking to raise up to $264 million with an offering of 11 million shares priced between $21 and $24 a share. That pricing would value the company a valuation of up to $1.91 billion.</p><p><blockquote>•锻造岩石<a href=\"https://www.marketwatch.com/investing/stock/FORG?mod=MW_story_quote&mod=article_inline\" target=\"_blank\">,</a>一家总部位于加州的身份安全平台希望通过发行1100万股股票，每股价格在21美元至24美元之间，筹集至多2.64亿美元。该定价将使该公司估值高达19.1亿美元。</blockquote></p><p> The stock is expected to list on the NYSE under the ticker symbol “FORG.” Morgan Stanley and JPMorgan are the lead underwriters. The company recorded a net loss of $41.8 million on revenue of $127.6 million in 2020, after a loss of $36.9 million on revenue of $104.5 million in 2019.</p><p><blockquote>该股预计将在纽约证券交易所上市，股票代码为“FORG”。摩根士丹利和摩根大通是主承销商。该公司在2020年录得净亏损4180万美元，营收为1.276亿美元，而2019年营收为1.045亿美元，亏损3690万美元。</blockquote></p><p> <b>•</b>Dice Therapeutics is expected to raise up to $170 million at a valuation of up to $583 million and list on Nasdaq under the ticker symbol “DICE.” The biotech is developing therapies to treat chronic diseases in the field of immunology.</p><p><blockquote><b>•</b>Dice Therapeutics预计将以高达5.83亿美元的估值筹集至多1.7亿美元，并在纳斯达克上市，股票代码为“DICE”。该生物技术公司正在免疫学领域开发治疗慢性疾病的疗法。</blockquote></p><p> <b>•</b>Surgical robotics developer Procept BioRobotics,is aiming to raise up to $132 million at a valuation of about $1 billion with plans to list on Nasdaq under the ticker symbol “PRCT.” BofA Securities and Goldman Sachs are lead underwriters.</p><p><blockquote><b>•</b>手术机器人开发商Procept BioRobotics计划以约10亿美元的估值筹集至多1.32亿美元，并计划在纳斯达克上市，股票代码为“PRCT”。美银证券和高盛是主承销商。</blockquote></p><p> “We develop, manufacture and sell the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia, or BPH,” the company says in its IPO documents.</p><p><blockquote>该公司在其IPO文件中表示：“我们开发、制造和销售AquaBeam机器人系统，这是一种先进的图像引导手术机器人系统，用于微创泌尿外科手术，最初重点是治疗良性前列腺增生（BPH）。”</blockquote></p><p> <b>•</b>Tyra Biosciences is aiming to raise $107.2 million in IPO proceeds at a valuation of $589 million. The biotech’s leading product candidate is a treatment for bladder cancer. It has applied to list on Nasdaq under the symbol “TYRA.”</p><p><blockquote><b>•</b>Tyra Biosciences的目标是通过IPO筹集1.072亿美元，估值为5.89亿美元。该生物技术公司的领先候选产品是膀胱癌的治疗方法。它已申请在纳斯达克上市，股票代码为“TYRA”。</blockquote></p><p> <b>•</b>EzFill Holdings, an app-based mobile fueling company in South Florida, is planning to raise $25 million at a valuation of $100 million. The company has applied to list on Nasdaq under the ticker symbol “EZFL.” ThinkEquity is sole underwriter.</p><p><blockquote><b>•</b>EzFill Holdings是一家位于南佛罗里达州的基于应用程序的移动加油公司，计划以1亿美元的估值筹集2500万美元。该公司已申请在纳斯达克上市，股票代码为“EZFL”。ThinkEquity是独家承销商。</blockquote></p><p> The Renaissance IPO ETF has gained 6% to date in 2021, while the S&P 500 has advanced 19%.</p><p><blockquote>2021年迄今为止，Renaissance IPO ETF已上涨6%，而标普500则上涨19%。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.marketwatch.com/story/busy-ipo-market-this-week-may-make-2021-the-biggest-year-for-proceeds-and-break-previous-record-by-30-11631554372?mod=home-page\">MarketWatch</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWKS":"Thoughtworks Holding Inc.","FORG":"ForgeRock, Inc.",".DJI":"道琼斯","ONON":"On Holding AG","BROS":"Dutch Bros Inc.","DRNA":"Dicerna Pharmaceuticals, Inc.","TYRA":"Tyra Biosciences, Inc.",".IXIC":"NASDAQ Composite","SRAD":"Sportradar Group AG","PRCT":"PROCEPT BioRobotics",".SPX":"S&P 500 Index","DH":"Definitive Healthcare Corp."},"source_url":"https://www.marketwatch.com/story/busy-ipo-market-this-week-may-make-2021-the-biggest-year-for-proceeds-and-break-previous-record-by-30-11631554372?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160275332","content_text":"Swiss running-shoe company backed by Roger Federer and drive-through coffee chain expected to hit the market this week \nSwiss tennis giant Roger Federer is a backer of one of this week's bigger IPOs.\n\n\nAfter a flurry of initial-public-offering launches last week set the market up for a busy fall for deals, 11 are expected to price this week and raise more than $3 billion in proceeds. \n\nIf all deals materialize, it will make 2021 the biggest year for IPO proceeds ever, and shatter the previous record by about 30%, according to Bill Smith, founder and chief executive of Renaissance Capital, a provider of institutional research and exchange-traded funds oriented around IPOs. The market is expected to see some 375 deals for the year, raising $125 billion, according to Renaissance, beating the $97 billion raised in 2000 during the dot-com boom. \n\n“After the long summer break, this week is a litmus test for upcoming tech, biotech, and consumer IPOs,” Smith wrote in a market commentary. The list includes a Swiss running-shoe company backed by tennis giant Roger Federer, a drive-through coffee kiosk operator and a mortgage insurer that was spun out of insurer Genworth Financial. \n\nThe biggest deal of the week is expected to come from Thoughtworks,a Chicago-based technology consultancy that will go public at a valuation of up to $6.1 billion.\nThe company, which expects to change its name from Turing Holding Corp. to Thoughtworks with completion of the IPO, said a total of 36.84 million shares will be offered, split between the company and selling shareholders.\n\nThe deal is expected to price at between $18 and $20 a share, and the stock will trade on the Nasdaq under the ticker symbol “TWKS.” Goldman Sachs and JPMorgan are the lead underwriters. The company recorded net income of $79.3 million on revenue of $803.4 million in 2020, after income of $28.4 million on revenue of $772.2 million in 2019.\nThe Swiss athletic-footwear maker On Holding is expected to raise up to $622 million at a valuation of almost $6 billion. On has applied to list 31.1 million shares priced at $18 to $20 each on the New York Stock Exchange, under the ticker symbol “ONON.”\n\nGoldman Sachs, Morgan Stanley and Morgan Stanley are lead underwriters in a syndicate of nine banks on the On deal. Proceeds are to be used for general corporate purposes. The company has a line that it co-developed with Federer.\n\nThe company had net income of 3.8 million Swiss francs ($4.1 million) in the six months through June 30, after a loss of 33.1 million francs in the year-earlier period, according to its IPO documents. Sales came to 315.5 million francs, up from 170.9 million francs.\n\nAlso from Switzerland, sports betting site Sportrader Group AG plans to offer 19 million shares priced at $25 to $28 each, for a valuation of up to $31 billion. The company has applied to list on Nasdaq under the ticker symbol “SRAD.” JPMorgan, Morgan Stanley, Citigroup and UBS are lead underwriters in a syndicate of 13 banks working on the deal.\n\nProceeds are to be used for working capital and to spur growth. The company had a net profit of $29.9 million in the first six months of the year, on revenue of $321 million, according to its filing documents.\n\nDutch Bros Inc.,an operator of drive-through shops that serve hot and cold drinks mostly in western U.S. states, is planning to offer 21.1 million shares priced at $18 to $20 each in its IPO, valuing the company at up to $3.3 billion.\n\nBofA Securities, JPMorgan and Jefferies are lead underwriters in a syndicate of 13 banks working on the deal. The company has applied to list on the New York Stock Exchange under the ticker symbol “BROS.”\nProceeds are to be used to purchase additional Class A shares — the company is planning to have four classes of stock with differing voting rights. The company had a net loss of $13.6 million, or 32 cents a share, in the first six months of the year, narrower than the loss of $16.5 million, or 38 cents a share, posted in the year-earlier period. Revenue fell to $227.9 million from $327.4 million.\n\nRounding out the list are:\n• Definitive Healthcare Corp., a Massachusetts-based provider of healthcare commercial intelligence, is planning to offer 15.56 million shares in its PO, which is expected to price between $21 and $24 a share. At that pricing, the company could be valued at up to $3.55 billion.\n• Enact Holdings Inc., a mortgage insurer owned by Genworth, is planning to offer 13.3 million shares priced at $19 to $20 each. The company would be valued at $3.3 billion at the top of that range. The company said all shares will be sold by Genworth and it will not receive any proceeds. It has applied to list on Nasdaq under the ticker “ACT.” Goldman Sachs and JPMorgan are lead underwriters in a team of nine banks working on the deal.\n• ForgeRock, a California-based identity security platform, is looking to raise up to $264 million with an offering of 11 million shares priced between $21 and $24 a share. That pricing would value the company a valuation of up to $1.91 billion.\nThe stock is expected to list on the NYSE under the ticker symbol “FORG.” Morgan Stanley and JPMorgan are the lead underwriters. The company recorded a net loss of $41.8 million on revenue of $127.6 million in 2020, after a loss of $36.9 million on revenue of $104.5 million in 2019.\n•Dice Therapeutics is expected to raise up to $170 million at a valuation of up to $583 million and list on Nasdaq under the ticker symbol “DICE.” The biotech is developing therapies to treat chronic diseases in the field of immunology.\n•Surgical robotics developer Procept BioRobotics,is aiming to raise up to $132 million at a valuation of about $1 billion with plans to list on Nasdaq under the ticker symbol “PRCT.” BofA Securities and Goldman Sachs are lead underwriters.\n“We develop, manufacture and sell the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia, or BPH,” the company says in its IPO documents.\n•Tyra Biosciences is aiming to raise $107.2 million in IPO proceeds at a valuation of $589 million. The biotech’s leading product candidate is a treatment for bladder cancer. It has applied to list on Nasdaq under the symbol “TYRA.”\n•EzFill Holdings, an app-based mobile fueling company in South Florida, is planning to raise $25 million at a valuation of $100 million. The company has applied to list on Nasdaq under the ticker symbol “EZFL.” ThinkEquity is sole underwriter.\nThe Renaissance IPO ETF has gained 6% to date in 2021, while the S&P 500 has advanced 19%.","news_type":1,"symbols_score_info":{".IXIC":0.9,"DRNA":0.9,"ONON":0.9,"TYRA":0.9,"BROS":0.9,"TWKS":0.9,"SRAD":0.9,"DH":0.9,"FORG":0.9,".DJI":0.9,".SPX":0.9,"PRCT":0.9,"ACT.UK":0.9}},"isVote":1,"tweetType":1,"viewCount":422,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":6,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/886541841"}
精彩评论